{
  "id": 9928410,
  "title": "Proto Labs CFO Daniel Schumacher sells $476,604 in stock",
  "url": "https://urgent.news/2026/09/26/proto-labs-cfo-daniel-schumacher-sells-476-604-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-26T06:30:51.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/proto-labs-cfo-daniel-schumacher-sells-476604-in-stock-93CH-4918493"
  },
  "original_language": "en",
  "account": "Proto Labs CFO Daniel Schumacher recently sold 5,000 shares of the company's common stock, resulting in a total value of $476,604. The sales took place on September 24, 2026, with share prices fluctuating between $95.00 and $95.65 per share. The weighted average price for these transactions was $95.3209 per share. This sale occurred as Proto Labs' stock was trading close to its 52-week high of $96.92, having delivered a strong 91% return over the past year. The transactions were carried out in accordance with a previously established Rule 10b5-1 trading plan adopted by Mr. Schumacher on June 5, 2026. Post-sale, Mr. Schumacher now holds a direct beneficial ownership of 35,019 shares of Proto Labs common stock. According to InvestingPro analysis, the company appears overvalued at present, trading at a P/E ratio of 76.4, implying that its shares are priced higher than many industry peers. For those seeking deeper insights, InvestingPro offers 13 additional ProTips and a wealth of detailed financial metrics for PRLB via its research platform. Recently, Proto Labs reported robust second-quarter results, surpassing Wall Street's estimates with a record revenue of $149.3 million and adjusted earnings of $0.60 per share. The company highlighted consistent growth across its manufacturing services, with its best quarter in three years. Moreover, Proto Labs has recorded three quarters of double-digit year-over-year growth and has raised its full-year revenue outlook. Needham recently upgraded Proto Labs' stock rating from Hold to Buy, setting a price target of $87.00, driven by the company's impressive growth momentum and operational enhancements under CEO Suresh Krishna. These developments illustrate Proto Labs' resurgence, marking the firm's strongest growth in five years.",
  "summary": null,
  "key_points": [
    "CFO Daniel Schumacher sold 5,000 shares of Proto Labs stock worth $476,604",
    "Sale occurred on September 24, 2026 when stock was near 52-week high",
    "Schumacher now owns 35,019 shares of Proto Labs after the transaction"
  ],
  "editors_take": "The sale of Proto Labs shares by CFO Daniel Schumacher comes as the company's stock is near a 52-week high and trading at a rich valuation, according to InvestingPro analysis.",
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}